{"id":3113,"date":"2025-01-22T11:50:42","date_gmt":"2025-01-22T09:50:42","guid":{"rendered":"https:\/\/www.ipsen.com\/spain\/?post_type=press_release&p=3113"},"modified":"2025-02-17T13:25:08","modified_gmt":"2025-02-17T11:25:08","slug":"lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal","status":"publish","type":"press_release","link":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","title":{"rendered":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal"},"content":{"rendered":"\n

<\/p>\n\n\n\n

Barcelona, 22 de enero de 2025<\/strong>.- Ipsen, compa\u00f1\u00eda biofarmac\u00e9utica global centrada en innovaci\u00f3n y
atenci\u00f3n especializada, ha nombrado a Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos
Regulatorios para Espa\u00f1a y Portugal. Desde su nuevo puesto, formar\u00e1 parte del Comit\u00e9 de Direcci\u00f3n y
reportar\u00e1 directamente a Aurora Berra de Unamuno, directora general de Ipsen Iberia. <\/p>\n\n\n\n

Luc\u00eda Regadera cuenta con m\u00e1s de 20 a\u00f1os de experiencia en la industria farmac\u00e9utica, donde ha
ocupado diferentes puestos de responsabilidad en diferentes \u00e1reas terap\u00e9uticas en GlaxoSmithKline y
AstraZeneca, as\u00ed como una amplia experiencia en el \u00e1mbito de la investigaci\u00f3n. Es licenciada en Medicina
y Cirug\u00eda por la Universidad Complutense de Madrid y especialista en Medicina Familiar y Comunitaria.
Posee un M\u00e1ster en Sistemas de Informaci\u00f3n Sanitaria y un Programa Ejecutivo en Alta Direcci\u00f3n de
Esade.<\/p>\n\n\n\n

\u201cMe uno a Ipsen en un momento en el que la Compa\u00f1\u00eda est\u00e1 creciendo mucho en el \u00e1rea de las enfermedades raras, lo que para m\u00ed supone un gran compromiso y una oportunidad para estar m\u00e1s cerca de estas personas y para trabajar por ofrecerles soluciones efectivas y terapias diferenciadas que satisfagan las necesidades no cubiertas<\/em>\u201d, ha explicado Luc\u00eda Regadera. \u201cAsumo la direcci\u00f3n m\u00e9dica y de asuntos regulatorios de Ipsen Iberia como una gran responsabilidad, que afronto con mucha ilusi\u00f3n y convencida de lo mucho que desde Ipsen podemos aportar para mejorar la calidad de vida de los pacientes<\/em>\u201d, ha a\u00f1adido la nueva directora m\u00e9dica.<\/p>\n\n\n\n

\u201cEstamos en un momento muy importante en la Compa\u00f1\u00eda, y estoy segura de que la dilatada experiencia de Lucia en la industria y en el \u00e1mbito de la investigaci\u00f3n van a ser muy importantes para progresar con \u00e9xito en esta etapa<\/em>\u201d, ha se\u00f1alado Aurora Berra de Unamuno, directora general de Ipsen Iberia.<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Para m\u00e1s informaci\u00f3n:<\/h3>\n\n\n\n
Ipsen<\/strong>

Loreto Gonz\u00e1lez<\/strong>
93 685 81 00
comunicacion.es@ipsen.com<\/strong><\/a><\/td>		DUOMO COMUNICACI\u00d3N<\/strong>

Borja G\u00f3mez<\/strong>
91 311 92 89 \/ 90
borja_gomez@duomocomunicacion.com<\/a><\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Sobre Ipsen<\/h3>\n\n\n\n

Somos una empresa biofarmac\u00e9utica global centrada en ofrecer f\u00e1rmacos transformadores para los pacientes en tres \u00e1reas terap\u00e9uticas: oncolog\u00eda, enfermedades raras y neurociencias.<\/p>\n\n\n\n

Nuestra cartera de productos est\u00e1 impulsada por la innovaci\u00f3n externa y respaldada por casi 100 a\u00f1os de experiencia en desarrollo y por nuestros centros de EE. UU., Francia y Reino Unido. Nuestros equipos, presentes en m\u00e1s de 40 pa\u00edses, y nuestras alianzas a lo largo del mundo nos permiten llevar medicamentos a los pacientes en m\u00e1s de 100 pa\u00edses.<\/p>\n\n\n\n

Ipsen cotiza en Par\u00eds (Euronext: IPN) y en EE. UU. a trav\u00e9s del American Depositary Receipt Program<\/em> patrocinado de nivel 1 (ADR: IPSEY). Para obtener m\u00e1s informaci\u00f3n, visite ipsen.com.<\/p>\n\n\n\n

Ipsen Pharma Espa\u00f1a<\/strong> se encuentra ubicada en Hospitalet de Llobregat (Barcelona). En Espa\u00f1a, la compa\u00f1\u00eda dispone de un s\u00f3lido porfolio en oncolog\u00eda (ri\u00f1\u00f3n, pr\u00f3stata, tiroides y tumores neuroendocrinos), enfermedades raras (acromegalia, colestasis intrahep\u00e1tica familiar progresiva (PFIC) y trastornos del crecimiento) y neurociencias (trastornos del movimiento). Para m\u00e1s informaci\u00f3n, visite ipsen.com\/Spain<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":73,"template":"","categories":[39],"tags":[],"class_list":["post-3113","press_release","type-press_release","status-publish","hentry","category-notas-de-prensa","entry"],"acf":[],"yoast_head":"\nLuc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\" \/>\n<meta property=\"og:site_name\" content=\"Spain\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-17T11:25:08+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\",\"url\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\",\"name\":\"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\"},\"datePublished\":\"2025-01-22T09:50:42+00:00\",\"dateModified\":\"2025-02-17T11:25:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/spain\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#website\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"name\":\"Spain\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#organization\",\"name\":\"Spain\",\"url\":\"https:\/\/www.ipsen.com\/spain\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/spain\/wp-content\/uploads\/sites\/17\/2024\/06\/Logo-Ipsen-new.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/spain\/wp-content\/uploads\/sites\/17\/2024\/06\/Logo-Ipsen-new.svg\",\"caption\":\"Spain\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","og_locale":"es_ES","og_type":"article","og_title":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","og_url":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","og_site_name":"Spain","article_modified_time":"2025-02-17T11:25:08+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","url":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","name":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal - Spain","isPartOf":{"@id":"https:\/\/www.ipsen.com\/spain\/#website"},"datePublished":"2025-01-22T09:50:42+00:00","dateModified":"2025-02-17T11:25:08+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/spain\/"},{"@type":"ListItem","position":2,"name":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/spain\/#website","url":"https:\/\/www.ipsen.com\/spain\/","name":"Spain","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/spain\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/spain\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/spain\/#organization","name":"Spain","url":"https:\/\/www.ipsen.com\/spain\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/spain\/wp-content\/uploads\/sites\/17\/2024\/06\/Logo-Ipsen-new.svg","contentUrl":"https:\/\/www.ipsen.com\/spain\/wp-content\/uploads\/sites\/17\/2024\/06\/Logo-Ipsen-new.svg","caption":"Spain"},"image":{"@id":"https:\/\/www.ipsen.com\/spain\/#\/schema\/logo\/image\/"}}]}},"parsely":{"version":"1.1.0","canonical_url":"https:\/\/ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Luc\u00eda Regadera Anechina, nueva directora M\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\u00f1a y Portugal","url":"http:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/","mainEntityOfPage":{"@type":"WebPage","@id":"http:\/\/www.ipsen.com\/spain\/press-releases\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\/"},"thumbnailUrl":"","image":{"@type":"ImageObject","url":""},"articleSection":"Notas de prensa","author":[{"@type":"Person","name":"loreto"}],"creator":["loreto"],"publisher":{"@type":"Organization","name":"Spain","logo":""},"keywords":[],"dateCreated":"2025-01-22T09:50:42Z","datePublished":"2025-01-22T09:50:42Z","dateModified":"2025-02-17T11:25:08Z"},"rendered":"<script type=\"application\/ld+json\" class=\"wp-parsely-metadata\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Luc\\u00eda Regadera Anechina, nueva directora M\\u00e9dica y de Asuntos Regulatorios de Ipsen para Espa\\u00f1a y Portugal\",\"url\":\"http:\\\/\\\/www.ipsen.com\\\/spain\\\/press-releases\\\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\\\/\",\"mainEntityOfPage\":{\"@type\":\"WebPage\",\"@id\":\"http:\\\/\\\/www.ipsen.com\\\/spain\\\/press-releases\\\/lucia-regadera-anechina-nueva-directora-medica-y-de-asuntos-regulatorios-de-ipsen-para-espana-y-portugal\\\/\"},\"thumbnailUrl\":\"\",\"image\":{\"@type\":\"ImageObject\",\"url\":\"\"},\"articleSection\":\"Notas de prensa\",\"author\":[{\"@type\":\"Person\",\"name\":\"loreto\"}],\"creator\":[\"loreto\"],\"publisher\":{\"@type\":\"Organization\",\"name\":\"Spain\",\"logo\":\"\"},\"keywords\":[],\"dateCreated\":\"2025-01-22T09:50:42Z\",\"datePublished\":\"2025-01-22T09:50:42Z\",\"dateModified\":\"2025-02-17T11:25:08Z\"}<\/script>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/ipsen.com\/p.js"},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/3113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release"}],"about":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/types\/press_release"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/users\/73"}],"version-history":[{"count":6,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/3113\/revisions"}],"predecessor-version":[{"id":3184,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/press_release\/3113\/revisions\/3184"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/media?parent=3113"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/categories?post=3113"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipsen.com\/spain\/wp-json\/wp\/v2\/tags?post=3113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}